ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Aduro Biotech Inc

Aduro Biotech Inc (ADRO)

14.595
0.00
(0.00%)
Closed September 18 4:00PM
14.595
0.00
( 0.00% )
Pre Market: 8:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
14.595
Bid
14.60
Ask
17.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
14.595
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ADRO Latest News

Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing

Combined Company Will Have Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol β€œKDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE...

Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics

One-for-Five Reverse Stock Split to be Effective October 2, 2020 BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical...

Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial Results

BERKELEY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the A Proliferation...

Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA Nephropathy

BERKELEY, Calif., June 24, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of...

Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual Congress

BION-1301 was well-tolerated, with no serious adverse events (SAEs), treatment discontinuations or events meeting stopping criteria, across a wide range of dosesPharmacokinetics (PK) of BION-1301...

Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement

– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy – Combined Company...

Aduro Biotech to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 57th ERA-EDTA Virtual Congress

BERKELEY, Calif., May 19, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of...

Aduro Biotech Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

BERKELEY, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of...

Aduro Biotech to Present at the Cowen and Company 40th Annual Health Care Conference

BERKELEY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TBIOTelesis Bio Inc
$ 4.23
(211.03%)
14.28M
ZEOZeo Energy Corporation
$ 2.85
(150.00%)
5.81M
XCURExicure Inc
$ 5.61
(144.98%)
4.78M
VEROVenus Concept Inc
$ 0.865
(72.14%)
6.34M
ACHLAchilles Therapeutics PLC
$ 0.98
(38.03%)
9.26M
HAOHaoxi Health Technology Ltd
$ 2.02
(-32.67%)
43.16k
PGNYProgyny Inc
$ 18.5733
(-24.00%)
169.46k
VVOSVivos Therapeutics Inc
$ 3.22
(-22.03%)
718.8k
WBUYWeBuy Global Ltd
$ 0.1455
(-21.05%)
2.04M
ATMCAlphaTime Acquisition Corporation
$ 9.00
(-19.64%)
10
FRGTFreight Technologies Inc
$ 0.1587
(28.09%)
35.51M
MAXNMaxeon Solar Technologies Ltd
$ 0.0986
(8.47%)
19.97M
TBIOTelesis Bio Inc
$ 4.23
(211.03%)
14.28M
SQQQProShares UltraPro Short QQQ
$ 7.87
(-6.31%)
10.75M
ACHLAchilles Therapeutics PLC
$ 0.98
(38.03%)
9.26M

ADRO Discussion

View Posts
nferna nferna 2 years ago
Nice run from 18 to 22 these past two weeks
πŸ‘οΈ0
k9narc k9narc 4 years ago
Symbol will be changing from ADRO to KDNY
πŸ‘οΈ0
k9narc k9narc 4 years ago
I expect it to, but that may be "hope" talking.

I bought while stoned...fat fingered the number of shares, so ended up with a pile. Averaged at 13.30/shr after split and am looking for 20.

Good luck.
πŸ‘οΈ0
Newc Newc 4 years ago
do you think this may go up some with the merger?
πŸ‘οΈ0
k9narc k9narc 4 years ago
The closing of the merger is anticipated to take place on or around October 5, 2020. Following closing of the merger, the combined company will be renamed Chinook Therapeutics and trade under the trading symbol β€œKDNY.”
πŸ‘οΈ0
k9narc k9narc 4 years ago
Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics....


https://www.globenewswire.com/news-release/2020/10/01/2102576/0/en/Aduro-Biotech-Stockholders-Approve-Merger-Agreement-with-Chinook-Therapeutics.html
πŸ‘οΈ0
k9narc k9narc 4 years ago
That was fun.... wake up to a 400%+ gainer and find out a R/S was the cause. I forgot that was coming. I guess we get our new ticker Monday.
πŸ‘οΈ0
k9narc k9narc 4 years ago
It was fun to watch today... up even more after hours.
πŸ‘οΈ0
Newc Newc 4 years ago
Ill be watching tomorrow.
πŸ‘οΈ0
k9narc k9narc 4 years ago
Seems investors don't like the upcoming merger....

"– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy

– Combined Company Will be Well-Funded With Cash Position of ~$200 Million Expected at Closing, Including $25 Million in Additional Investment Committed by Chinook’s Existing Investors"

https://www.globenewswire.com/news-release/2020/06/02/2042120/0/en/Aduro-Biotech-and-Chinook-Therapeutics-Announce-Definitive-Merger-Agreement.html

πŸ‘οΈ0
beebread beebread 4 years ago
my thoughts: going higher
πŸ‘οΈ0
k9narc k9narc 4 years ago
Any thoughts on the 20%+ bounce on this today, or am I the only nut playing this?

CBOE BZX REAL-TIME LAST SALE
2.79 USD

TODAY'S CHANGE
+0.51increase +22.37%increase

VOLUME
982,159

PRICE QUOTE AS OF
13:41 ET
πŸ‘οΈ0
k9narc k9narc 4 years ago
Any thoughts on the merger?
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-14-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-13-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-07-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-05-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-04-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Stockslayr Stockslayr 5 years ago
Gandalf standing at the $2 resistance
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 02-03-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Stockslayr Stockslayr 5 years ago
Near the HOD. How about 2 bones tomorrow??
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 01-31-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
makinezmoney makinezmoney 5 years ago
$ADRO: Wow.... $7price target


SVB Leerink just raised it from $3 target


Buy all you can here at $1.63


And don't hold back.


This could really go.


I'm in for sure !



GO $ADRO
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ADRO Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Honolulu Trader Honolulu Trader 5 years ago
1.05

1/2
πŸ‘οΈ0
PennyStock Alert PennyStock Alert 5 years ago
They stole ADXS's crumbs and now are reeling from the disaster!
πŸ‘οΈ0
willlbone willlbone 5 years ago
Phase 1b Stung.
πŸ‘οΈ0
jondoeuk jondoeuk 5 years ago
ASCO title https://meetinglibrary.asco.org/record/172413/abstract
πŸ‘οΈ0
strongstock strongstock 6 years ago
Rated strong buy- could see some volume soon...

https://finance.yahoo.com/news/aduro-biotech-adro-upgraded-strong-140902253.html
πŸ‘οΈ0
10bags 10bags 6 years ago
ADRO ready for a 50%+ move
Big partners

Elly lilly
Novartis
Merck

Milestone payments

3.30 cash per share
2.00 book value.

Chart set up for a move
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
A new preclinical paper https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31810-2
πŸ‘οΈ0
ClayTrader ClayTrader 6 years ago
* * $ADRO Video Chart 12-19-18 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
LOOKS LIKE I WILL BE TWERKING... ALL THE WAY TO THE BANK -->>
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
N thats how you take care of business!!! Yeall have a nice day!!!
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
FROM HERE ON OUT $HIT BE FADING AWAY!!! $$$$$$$ -->>

IM SO FUC.ING TIT$

πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
IM SOOOOO DRIPPIE -->>
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
WHO THE F... IS GONNA STEPUP??? NOONE!!! IM THE BEST WATCH ME FLEX THIS SHORT GAME EVERY DAY PLAYAZ!!!
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
I AM UNLIMITED!!! AINT NOBODY BETTA DEN ME!!! BUT AT LEAST YOU CAN GET A TASTE -->>
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 6 years ago
SHORT ADRO $3.15
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
Here is another http://www.codiakbio.com/press-releases/codiak-biosciences-presents-first-data-on-exosting-a-novel-engineered-exosome-therapeutic-targeting-checkpoint-refractory-tumors-at-the-society-for-immunotherapy-of-cancers-33rd-ann/
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
In one interview Dr. Jaffee said a pilot trial investigating a neoantigen vaccine (synthetic long peptides plus STING adjuvant), anti-OX40 and anti-PD-1 will take place in patients with MSS CRC and mPADC. Here is the preclinical study https://insight.jci.org/articles/view/122857
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
Dr. Luke presented data on $BMY's STING agonist [1] as well as one by $SBPH [2] and Actym Therapeutics [3].

1 https://pbs.twimg.com/media/DtUqr7-WsAAkxFv.jpg
2 https://pbs.twimg.com/media/DtUqr7_WkAEWxuN.jpg
3 https://pbs.twimg.com/media/DtUqr8DWwAAlai1.jpg
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
Most had failed a number of lines of therapy and over 46% had treatment with a checkpoint inhibitor. So you shouldn't expect to see much evidence for efficacy in a PhIa trial. The main purpose of these is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of a drug.
πŸ‘οΈ0
XXSPOWER XXSPOWER 6 years ago
what about the 35 out of 41 (85%) pts that stopped treatment STING SINGLE AGENT
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
SITC abstract https://pbs.twimg.com/media/DrUnGSyXcAA6Wvh.jpg

The company will host and webcast an investor event on Friday, November 9, 2018 at 6:30 p.m. Eastern Time in Washington, D.C.
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
It should activate the pathway in multiple cells in the TME (including macrophages and ECs to name of few). The innate response is via neutrophils after TNFa has caused hemorrhagic necrosis. Adaptive response is dependent on STING and IFNB activation in DCs. Abscopal effects through polyfunctional antigen specific T-cells.
πŸ‘οΈ0
Murph1953 Murph1953 6 years ago
Does ADRO's STING stimulate the same immune cells as AFMD's NK, Natural Killer cells, or does ADRO stimulate T-cells(which kill) and B-cells(which produce antibodies)?

Would really appreciate your answer.

Thanks
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
Personalised LADD won't be moving forward after the current PhI is completed. The company now looks to licence it.
πŸ‘οΈ0
jondoeuk jondoeuk 6 years ago
$JNJ has terminated the exclusive global license agreement to develop ADU-214, ADU-741 and GVAX Prostate for all indications. From the wording I don't hold out much hope for pLADD.

https://www.sec.gov/Archives/edgar/data/1435049/000119312518289503/d619516d8k.htm
πŸ‘οΈ0
CATTDOGG12347 CATTDOGG12347 6 years ago
I will no longer buy Advaxis common stock and I will not recommend it to anybody I like. I will however continue to hold my shares and vote NO to everything management wants until they sell the company.
Anybody who does their job with such ineptitude as the BOD and management of this company doesn’t deserve to have a job.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock